|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.199
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.147
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.116
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.114
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.112
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.103
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.101
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.099
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.086
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.083
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.080
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.077
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.077
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.076
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.072
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.070
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.067
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.062
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.060
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.058
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.058
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.058
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.057
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.057
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.057
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.055
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.054
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.053
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.050
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.050
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.050
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.049
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.047
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.047
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.045
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.045
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.045
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.044
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.043
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.042
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.042
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.041
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.041
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.039
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.039
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.039
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.039
|
|
|
|
translation
|
GO:0006412 |
93 |
0.038
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.038
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.038
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.038
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.038
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.037
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.037
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.037
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.037
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.036
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.036
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.036
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.036
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.034
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.033
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
epiblast cell extraembryonic ectoderm cell signaling involved in anterior posterior axis specification
|
GO:0060802 |
1 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.033
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.033
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.033
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.033
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.032
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.032
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.032
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.031
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.031
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.030
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.030
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.029
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.029
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.029
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.029
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.029
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.029
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.029
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.029
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.028
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.028
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.028
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.028
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.028
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.028
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.028
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.027
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.026
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.026
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.025
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.025
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.025
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.025
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.024
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.024
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.024
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.024
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.024
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.023
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.023
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.023
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.023
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.023
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.023
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.023
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.023
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.023
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.022
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.022
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.022
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.022
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.022
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.022
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.022
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.022
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.021
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.021
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.021
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.021
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.021
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.020
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.020
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.020
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.020
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.020
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.020
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.020
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.020
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.020
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.019
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.019
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.019
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.019
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.019
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.018
|
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.018
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.018
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.018
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.018
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.018
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.018
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.018
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.018
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.017
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.017
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.017
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.017
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.017
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.016
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.016
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.016
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.016
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.016
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.016
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.016
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.016
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.015
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.015
|
|
|
|
nodal signaling pathway
|
GO:0038092 |
10 |
0.015
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.015
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.015
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.015
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.015
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.015
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.015
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.015
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.015
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.015
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.015
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.014
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.014
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.014
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.014
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.014
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.014
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.014
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.014
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.014
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.014
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.014
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.014
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.014
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.014
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.014
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.014
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.014
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.014
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.014
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.013
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.013
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.013
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.013
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.013
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.013
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.013
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.013
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.013
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.013
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.013
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.013
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.013
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.013
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.013
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.013
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.013
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.013
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.013
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.013
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.013
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.012
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
|
energy homeostasis
|
GO:0097009 |
15 |
0.012
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.012
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.012
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.012
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.012
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.012
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.012
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.012
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.012
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.012
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.012
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.012
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.012
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.012
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.012
|
|
|
|
methionine transport
|
GO:0015821 |
1 |
0.012
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.012
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.012
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.012
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.012
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.012
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.012
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.012
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.012
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.012
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.012
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.012
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.012
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.012
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.012
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.011
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.011
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.011
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.011
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.011
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.011
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.011
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.011
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.011
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.011
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.011
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.011
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.011
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.011
|
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.011
|
|
|
|
negative regulation of alkaline phosphatase activity
|
GO:0010693 |
3 |
0.011
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.011
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.011
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.011
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.011
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.011
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.011
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.011
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.011
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.011
|
|
|
|
cellular magnesium ion homeostasis
|
GO:0010961 |
3 |
0.011
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.011
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.011
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.011
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.011
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.011
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.011
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.011
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.011
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.011
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.011
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.011
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.010
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.010
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.010
|
|
|
|
intestinal epithelial cell differentiation
|
GO:0060575 |
14 |
0.010
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.010
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.010
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.010
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.010
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.010
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.010
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.010
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.010
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.010
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.010
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.010
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.010
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.010
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.010
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.010
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.010
|
|
|
|
terpenoid biosynthetic process
|
GO:0016114 |
7 |
0.010
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.010
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.010
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.010
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.010
|
|
